Skip to main content
Log in

Das Burkitt-like Lymphom: Differentialdiagnose, Klinik und Therapie

The Burkitt-like lymphoma: Diagnosis, clinical features, and response to chemotherapy

  • Übersichten
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

The Burkitt-like lymphoma is extremely rare. It shows a predominance of presentation in abdominal and pelvic sites and an older median age as compared to the endemic Burkitt's lymphoma. Both are independent prognostic determinants and reflect a poor prognosis. This might be the reason for the low response rate to cytotoxic treatment. Cyclophosphamide is a substantial part of any chemotherapeutic regimen used. Serum lactic dehydrogenase (LDH) levels are closely correlated with the extent of tumor mass and the response to therapy. Chemotherapy might be associated with serious metabolic complications including hyperkalemia, lactic acidosis, anuria, and sudden death from lethal embolization of the lung. In contrast to Burkitt's lymphoma, the Burkitt-like tumor has no association with the Epstein-Barr-virus. In both lymphomas a translocation from the 8q onto 14q chromosome occurs being a characteristic marker for these malignancies.

Zusammenfassung

Das Burkitt-like Lymphom (BLL) ist insgesamt sehr selten. Es zeigt im Vergleich zum afrikanischen Burkitt-Lymphom (BL) häufiger einen Befall des Abdomen und tritt in höheren Altersgruppen auf. Beides ist prognostisch ungünstig. Dadurch mag auch die schlechtere therapeutische Ansprechbarkeit des BLL bedingt sein. Jede zytostatische Therapie sollte Cyclophosphamid als wesentlichen Bestandteil beinhalten. Die Serum-Lactatdehydrogenase hat sich als zuverlässiger Verlaufsparameter sowohl hinsichtlich der klinischen Ausbreitung als auch der Wirksamkeit einer Therapie dieses Lymphoms herausgestellt. An Therapie-bedingten Komplikationen sind vor allem die Hyperkaliämie, Lactatacidose, Anurie und tödliche Lungenembolie zu erwähnen. — Im Unterschied zum BL zeigt das BLL keine Assoziation mit dem Epstein-Barr-Virus, während bei beiden malignen Lymphomen die Translokation von Chromosom 14q ein sicherer Marker ist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  1. Andersson, M., Klein, G., Ziegler, J.L., Henle, W.: Association of Epstein-Barr viral genomes with American Burkitt lymphoma. Nature (Lond.)260, 357, 1976

    Google Scholar 

  2. Arsenau, J.C., Canellos, G.P., Banks, P.M., Berard, C.W., Gralnick, H.R., DeVita, T.V.: American Burkitt's lymphoma: A clinicopathologic study of 30 cases. Am J. Med.58, 314, 1975

    Google Scholar 

  3. Banks, P.M., Arsenau, J.C., Gralnick, H.R., Canellos, G.P., DeVita, V.T., Berard, C.W.: American Burkitt's lymphoma: A clinicopathologic study of 30 cases. II Pathologic correlations. Am. J. Med.58, 322, 1975

    Google Scholar 

  4. Berard, C.W., O'Connor, G.T., Thomas, L.B., Torloni, H.: Histopathological definition of Burkitt's tumor. W.H.O. Bull.40, 601, 1969

    Google Scholar 

  5. Block, J.B., Bronson, W.R., Bell, W.R.: Metabolic abnormalities of lactic acid in Burkitt's type lymphoma with malignant effusions. Ann. Int. Med.65, 101, 1966

    Google Scholar 

  6. Bluming, A.Z., Templeton, A.C.: Histological diagnosis of Burkitt's lymphoma: A cautionary tale. Brit. Med. J.1, 89, 1971

    Google Scholar 

  7. Bluming, A.Z., Ziegler, J.L., Carbone, P.P.: Bone marrow involvement in Burkitt's lymphoma: Results of a prospective study. Br. J. Haematol.22, 369, 1972

    Google Scholar 

  8. Brearley, R.L., Lister, T.A., Whitehouse, J.M.A., Stansfield, A.G.: Burkitt's lymphoma in British adults: clinical features and response to chemotherapy. Br. J. Cancer35, 484, 1977

    Google Scholar 

  9. Drury, R.A.B., Wallnigton, E.A.: Carleton's Histological Technique. 4th edn., p. 41, London, Oxford University Press 1967

    Google Scholar 

  10. Fialkow, P.J., Klein, E., Klein, G., Clifford, P., Singh, S.: Immunglobulin and glucose-6-phosphate dehydrogenase as markers of cellular origin in Burkitt's lymphoma. J. Exp. Med.138, 89, 1973

    Google Scholar 

  11. Flandrin, G., Brouet, J.C., Daniel, M.T., Preud'Homme, J.L.: Acute leukemia with Burkitt's tumor cells: A study of six cases with special reference to lymphocyte surface markers. Blood45, 183, 1975

    Google Scholar 

  12. Gérard-Marchant, R., Hamlin, J., Lennert, K., Ricke, F., Stansfield, A.G., van Unnik, J.A.M.: Classification of non-Hodgkin's lymphomas. (Letter to the Editor) Lancet II 406, 1974

    Google Scholar 

  13. Gravell, M., Levine, P.H., McIntyre, R.F. et al.: Epstein-Barr virus in an American patient with Burkitt's lymphoma: dedection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB). J. Natl. Cancer Inst.56, 701, 1976

    Google Scholar 

  14. Henle, W., Henle, G., Gunvén, P., Klein, G., Clifford, P., Singh, S.: Patterns of antibodies to Epstein-Barr virusinduced early antigens in Burkitt's lymphoma. Comparison of dying patients with long-term survivors. J. Natl. Cancer Inst.50, 1173, 1973

    Google Scholar 

  15. Hirshaut, Y., Cohen, M.H., Stevens, D.A.: Epstein-Barr virus antibodies in American and African Burkitt's lymphoma. Lancet2, 114, 1973

    Google Scholar 

  16. Jarvis, J.E., Bill, G., Rickinson, A.B., Epstein, M.A.: Cytogenetic studies on human lymphoblastoid cell lines from Burkitt's lymphomas and other sources. Int. J. Cancer14, 716, 1974

    Google Scholar 

  17. Judson, S.C., Henle, W., Henle, G.: A cluster of Epstein-Barrvirus associated American Burkitt's lymphoma. New Engl. J. Med.297, 464, 1977

    Google Scholar 

  18. Kaiser-McCaw, B., Epstein, A.L., Kaplan, H.S., Hecht, F.: Chromosome 14 translocation in African and North American Burkitt's lymphoma. Int. J. Cancer19, 482, 1977

    Google Scholar 

  19. Levine, P.H., O'Connor, G.T., Berard, C.W.: Antibodies to Epstein-Barr-virus in American patients with Burkitt's lymphoma. Cancer30, 610, 1972

    Google Scholar 

  20. Levine, P.H., Cho, B.S., Connelly, R.R., O'Connor, G.T., Dorfman, R.F., Easton, J.M., DeVita, T.V.: The American Burkitt lymphoma registry — A progress report. Ann. Int. Med.83, 31, 1975

    Google Scholar 

  21. Lindahl, T., Klein, G., Reedman, B.M., Johansson, B., Singh, S.: Relationship between Epstein-Barr-virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt's lymphoma biopsies and other lympho-proliferative malignancies. Int. J. Cancer13, 764, 1974

    Google Scholar 

  22. Mann, R.B., Jaffee, E.S., Braylan, R.C., Namba, K., Frank, M., Ziegler, J.L., Berard, C.W.: Non-endemic Burkitt's lymphoma: a B-cell tumor related to germinal centres. New Engl. J. Med.295, 685, 1976

    Google Scholar 

  23. Pagano, J.S., Huang, C.H., Levine, P.H.: Absence of Epstein-Barr viral DNA in American Burkitt's lymphoma. New Engl. J. Med.289, 1395, 1973

    Google Scholar 

  24. Philip, P.: Marker chromosome 14q+in multiple myeloma. Hereditas80, 155, 1975

    Google Scholar 

  25. Philip, P., Ernst, P., Lange-Wantzin, G.: Karyotypes in infectious mononucleosis. Scand. J. Haematol.15, 201, 1975

    Google Scholar 

  26. Philip, G., Jensen, M.K., Pallensen, G.: Marker chromosome 14q+in non-endemic Burkitt's lymphoma. Cancer39, 1495, 1977

    Google Scholar 

  27. Pitts, J.R., Cowley, A.: Non-African Burkitt lymphoma presenting as dysphagia. Postgard. Med. J.53, 276, 1977

    Google Scholar 

  28. Prigogina, E.L., Fleischman, E.W.: Marker chromosome 14q+in two non-Burkitt lymphomas. Humangenetik30, 109, 1975

    Google Scholar 

  29. Rappaport, H., Wright, D.H., Dorfman, R.F.: Suggested criteria for the diagnosis of Burkitt's tumor. Cancer Res.27, 2635, 1967

    Google Scholar 

  30. Siegel, M.B., Alexander, E.A., Weintraub, L. et al.: Renal failure in Burkitt's lymphoma. Clin. Nephrol.7, 279, 1977

    Google Scholar 

  31. Stutz, A.J., Greenberg, A.J., Wiley, A., Gilbert, E.F., Oppenheimer, J.: Burkitt's Lymphoma: The role of radiotherapy. Radiol.104, 379, 1972

    Google Scholar 

  32. Wilmanns, W., Wilms, K., Koos, Th.: Langzeitremissionen bei fortgeschrittenen Stadien der Lymphogranulomatose nach kombinierter Chemotherapie mit einem modifizierten DeVita-Schema. In: Maligne Lymphome und monoklonale Gammopathien. (Ed. Löffler, H., 109, Blut Suppl. Bd. 18. München: Lehmanns Verlag 1977

    Google Scholar 

  33. Wright, D.H.: Burkitt's tumor and childhood lymphosarcoma. Clin. Pediat.6, 116, 1967

    Google Scholar 

  34. Ziegler, J.L.: Chemotherapy of Burkitt's lymphoma. Cancer30, 1534, 1972

    Google Scholar 

  35. Ziegler, J.L., Bluming, A.Z., Fass, L., Morrow, R.H.: Relapse patterns in Burkitt's lymphoma. Cancer Res.32, 1267, 1972

    Google Scholar 

  36. Ziegler, J.L., Magrath, I.T.: Treatment of Burkitt's lymphoma. Pathobiol. Ann. 4: 129, 1974 H.L. Joachim Ed., N.Y., Appleton-Century Crofts

    Google Scholar 

  37. Ziegler, J.L., DeVita, V.T., Graw, R.G., Herzig, G., Leventhal, B., Levine, A.S., Pomery, T.C.: Combined modality treatment of American Burkitt's lymphoma. Cancer38, 2225, 1976

    Google Scholar 

  38. Ziegler, J.L.: Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience. New Engl. J. ed.297, 75, 1977

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Herrn Professor Dr. Dr. h.c. H.E. Bock zum 75. Geburtstag in Verehrung und Dankbarkeit gewidmet

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jehn, U., Wohlrab, A. & Wilmanns, W. Das Burkitt-like Lymphom: Differentialdiagnose, Klinik und Therapie. Klin Wochenschr 57, 1089–1096 (1979). https://doi.org/10.1007/BF01481489

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01481489

Key words

Schlüsselwörter

Navigation